Viewing Study NCT05398003


Ignite Creation Date: 2025-12-24 @ 7:39 PM
Ignite Modification Date: 2026-01-03 @ 11:07 PM
Study NCT ID: NCT05398003
Status: RECRUITING
Last Update Posted: 2024-11-18
First Post: 2022-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M)
Sponsor: Nantes University Hospital
Organization:

Study Overview

Official Title: Evaluation of Multimodal Medullary Stimulation in Refractory Neck and Upper Limb Pain
Status: RECRUITING
Status Verified Date: 2024-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: S2M
Brief Summary: Number of centres planned : 1 (CHU Nantes)

Design : Randomized, Prospective

Planning of the study :

* Total duration: 34 months
* Recruitment period: 24 months.
* Follow-up time per patients : 7-10 months

Expected number of cases : 12

Treatment, procedure, combination of procedures under consideration :

During the study, patients will be implanted with the WAVEWRITER ALPHAâ„¢ system with the objective of decreasing patient pain with a spinal cord stimulation mode.

There will be a random draw on the order of the stimulation program:

* the tonic stimulation "LF": In tonic mode, the electrical stimulation of the sensory fibers of the posterior cords of the spinal cord induces local paresthesias
* burst stimulation (or "burst")
* high frequency" stimulation (1000 Hz) "High frequency: HF".
* combined tonic + burst stimulation
* combined tonic + high frequency stimulation
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: